D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 33,180 339 World Ranking 13138 National Ranking 6842

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Disease

His primary areas of investigation include Alzheimer's disease, Internal medicine, Dementia, Disease and Psychiatry. Alzheimer's disease is a primary field of his research addressed under Pathology. Stephen Salloway works mostly in the field of Internal medicine, limiting it down to concerns involving Placebo and, occasionally, Clinical trial.

His Dementia study combines topics from a wide range of disciplines, such as Hyperintensity and Pediatrics. The various areas that Stephen Salloway examines in his Disease study include Biomarker and Neuroscience. His work on Depression, Cognitive disorder and Apathy is typically connected to In patient as part of general Psychiatry study, connecting several disciplines of science.

His most cited work include:

  • Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2062 citations)
  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)
  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease (1163 citations)

What are the main themes of his work throughout his whole career to date?

Stephen Salloway spends much of his time researching Disease, Dementia, Internal medicine, Alzheimer's disease and Neuroscience. His research integrates issues of Biomarker, Cognition, Cerebrospinal fluid and Intensive care medicine in his study of Disease. His Dementia study integrates concerns from other disciplines, such as Positron emission tomography, Psychiatry, Neuroimaging and Pediatrics.

His work on Depression and Neuropsychiatry as part of general Psychiatry study is frequently linked to In patient, therefore connecting diverse disciplines of science. His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Oncology. His study on Alzheimer's disease is covered under Pathology.

He most often published in these fields:

  • Disease (37.16%)
  • Dementia (33.61%)
  • Internal medicine (28.42%)

What were the highlights of his more recent work (between 2018-2021)?

  • Disease (37.16%)
  • Dementia (33.61%)
  • Internal medicine (28.42%)

In recent papers he was focusing on the following fields of study:

Stephen Salloway mainly focuses on Disease, Dementia, Internal medicine, Neuroscience and Alzheimer's disease. His Disease study combines topics in areas such as Clinical trial, Bioinformatics, Intensive care medicine, Biomarker and Atrophy. His research in Dementia intersects with topics in Differential item functioning and Functional impairment.

His studies in Internal medicine integrate themes in fields like Cognition, Oncology and Cardiology. His work in Neuroscience covers topics such as Neurodegeneration which are related to areas like Cerebrospinal fluid. His biological study focuses on Clinical Dementia Rating.

Between 2018 and 2021, his most popular works were:

  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (238 citations)
  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. (75 citations)
  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. (75 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

His main research concerns Disease, Dementia, Alzheimer's disease, Internal medicine and Neuroscience. His Disease research is multidisciplinary, incorporating perspectives in Atrophy, Clinical trial, Bioinformatics and Cerebrospinal fluid. In the subject of general Dementia, his work in Dementia research is often linked to Cultural diversity, thereby combining diverse domains of study.

His Alzheimer's disease study incorporates themes from Asymptomatic, Messenger RNA, Positron emission tomography, Pediatrics and Cohort. Stephen Salloway has included themes like Cognition and Oncology in his Internal medicine study. His work on Hippocampus, Stimulation, Hippocampal stimulation and Corpus callosum as part of general Neuroscience study is frequently linked to Deep brain stimulation, bridging the gap between disciplines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan.
The New England Journal of Medicine (2012)

3239 Citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2859 Citations

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny;Ping Chiao;Thierry Bussière;Paul H Weinreb.
Nature (2016)

1971 Citations

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow.
The New England Journal of Medicine (2014)

1735 Citations

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens.
Alzheimers & Dementia (2016)

1218 Citations

Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression

Donald A. Malone;Darin D. Dougherty;Ali R. Rezai;Linda L. Carpenter.
Biological Psychiatry (2009)

884 Citations

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox.
Neurology (2009)

822 Citations

Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder

Benjamin D Greenberg;Donald A Malone;Gerhard M Friehs;Ali R Rezai.
Neuropsychopharmacology (2006)

810 Citations

Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

B D Greenberg;Lutgardis Gabriëls;D A Malone;A R Rezai.
Molecular Psychiatry (2010)

779 Citations

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez.
Nature Communications (2016)

720 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stephen Salloway

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 512

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 483

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 186

Philip Scheltens

Philip Scheltens

Amsterdam UMC

Publications: 180

John C. Morris

John C. Morris

Washington University in St. Louis

Publications: 160

William J. Jagust

William J. Jagust

University of California, Berkeley

Publications: 155

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 148

Pieter Jelle Visser

Pieter Jelle Visser

Amsterdam University Medical Centers

Publications: 148

Keith A. Johnson

Keith A. Johnson

Harvard University

Publications: 141

Alzheimer's Disease Neuroimaging Initiative

Alzheimer's Disease Neuroimaging Initiative

University of North Carolina at Chapel Hill

Publications: 134

Gil D. Rabinovici

Gil D. Rabinovici

University of California, San Francisco

Publications: 131

Oskar Hansson

Oskar Hansson

Lund University

Publications: 129

Harald Hampel

Harald Hampel

Eisai (United States)

Publications: 127

Agneta Nordberg

Agneta Nordberg

Karolinska University Hospital

Publications: 120

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 120

Rik Ossenkoppele

Rik Ossenkoppele

Lund University

Publications: 119

Trending Scientists

Mark Liberman

Mark Liberman

University of Pennsylvania

Xuezhe Zheng

Xuezhe Zheng

Innolight Technology Research Institute

Kun Wu

Kun Wu

Harbin Institute of Technology

Michael Kyba

Michael Kyba

University of Minnesota

Michael L. Berumen

Michael L. Berumen

King Abdullah University of Science and Technology

Stein Ove Døskeland

Stein Ove Døskeland

University of Bergen

Stefan Ståhl

Stefan Ståhl

KTH Royal Institute of Technology

Volker Brinkmann

Volker Brinkmann

Max Planck Society

Paul A. Mueller

Paul A. Mueller

University of Florida

Rebecca A. Lange

Rebecca A. Lange

University of Michigan–Ann Arbor

Rainer Gersonde

Rainer Gersonde

Alfred Wegener Institute for Polar and Marine Research

Hitoshi Mukai

Hitoshi Mukai

National Institute for Environmental Studies

Akira Takashima

Akira Takashima

University of Toledo

Pierce K. H. Chow

Pierce K. H. Chow

Singapore General Hospital

Rajesh Agarwal

Rajesh Agarwal

University of Colorado Anschutz Medical Campus

M. Symeonidis

M. Symeonidis

University College London

Something went wrong. Please try again later.